Plasma Protein Treatment Methods
Summary
The European Patent Office published patent application EP4153236A1, granting protection for methods of treating plasma protein imbalances or depletion to Ohio State Innovation Foundation and The Regents of the University of California. The patent covers therapeutic compositions and methods using specified compounds for treating conditions including hemorrhage, hypovolemia, and shock.
What changed
The EPO published patent EP4153236A1 for methods treating plasma protein imbalances or depletion, filed by Ohio State Innovation Foundation and The Regents of the University of California. The patent covers therapeutic methods using plasma protein compositions and related compounds, classified across multiple IPC categories including A61K, C07K, and A61P codes.
For pharmaceutical and biotechnology companies developing plasma protein therapies or blood substitutes, this patent establishes IP protection in European markets across 31 designated states. Parties operating in the hemotherapy, fluid resuscitation, or critical care sectors should assess freedom-to-operate implications for related product development in EU jurisdictions.
What to do next
- Monitor for updates
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS FOR TREATING PLASMA PROTEIN IMBALANCES OR DEPLETION
Publication EP4153236A1 Kind: A1 Apr 01, 2026
Applicants
Ohio State Innovation Foundation, The Regents of the University of California
Inventors
SUSIN PIRES, Ivan, PALMER, Andre, CABRALES AREVALO, Pedro J.
IPC Classifications
A61K 31/555 20060101AFI20240523BHEP A61K 31/195 20060101ALI20240523BHEP A61K 35/16 20150101ALI20240523BHEP A61K 38/17 20060101ALI20240523BHEP A61K 38/40 20060101ALI20240523BHEP A61K 38/38 20060101ALI20240523BHEP A61K 39/395 20060101ALI20240523BHEP A61K 45/06 20060101ALI20240523BHEP C07K 16/28 20060101ALI20240523BHEP A61P 7/08 20060101ALI20240523BHEP A61P 9/00 20060101ALI20240523BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.